Recent advances in pre-exposure prophylaxis for HIV

Monica Desai1, Nigel Field2, Robert Grant3

  • 1HIV and STI Department, Public Health England, London NW9 5EQ, UK.

BMJ (Clinical Research Ed.)
|December 13, 2017
PubMed
Summary

Pre-exposure prophylaxis (PrEP) with emtricitabine-tenofovir disoproxil fumarate is highly effective and safe for HIV prevention. However, challenges in access and adherence remain critical public health concerns.